1. Endovascular Treatment of Epistaxis
- Author
-
Joan C. Wojak
- Subjects
medicine.medical_specialty ,education.field_of_study ,medicine.diagnostic_test ,business.industry ,General surgery ,medicine.medical_treatment ,Population ,Interventional radiology ,030204 cardiovascular system & hematology ,030218 nuclear medicine & medical imaging ,Review article ,03 medical and health sciences ,0302 clinical medicine ,medicine.artery ,Epidemiology ,medicine ,Radiology, Nuclear Medicine and imaging ,Embolization ,Endovascular treatment ,Cardiology and Cardiovascular Medicine ,business ,education ,Sphenopalatine artery ,Medical attention - Abstract
Epistaxis is not uncommon, with up to 60% of the population suffering from at least one episode in their lifetime and as many as 6% presenting for medical attention. An analysis of emergency room (ER) visits in the United States between 2009 and 2011 identified 1.2 million encounters for epistaxis, accounting for 0.32% of ER visits. Approximately 6% of patients will require more aggressive, invasive management in the form of transnasal ligation of the sphenopalatine artery or endovascular embolization. This article reviews the epidemiology, rationale for endovascular treatment, strategy for treatment, endovascular technique, postprocedural follow-up, and complications and their management.
- Published
- 2020
- Full Text
- View/download PDF